Peterson Wealth Services’s GSK GSK Stock Holding History

Peterson Wealth Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.39K	Buy	+160	New	+$8.46K	﹤0.01%	190

Other funds holding GSK

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Peterson Wealth Services's GSK Position: Q2 2026 in Review

Peterson Wealth Services opened a new position in GSK (GSK) in Q2 2026: 160 shares worth $8.39K. The stake represents ﹤0.01% of the portfolio and ranks #190 among its holdings.

439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Peterson Wealth Services held 160 shares of GSK worth $8.39K as of Q2 2026.
GSK was a new Peterson Wealth Services position in Q2 2026.
GSK made up ﹤0.01% of Peterson Wealth Services's portfolio in Q2 2026, its #190 holding.
439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Peterson Wealth Services's 13F filing for Q2 2026, filed 27 Jul 2026.